未登录

Y

Yifei Guo

Tianjin University of Traditional Chinese Medicine

H指数:9

被引数:819

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Breaking the Feedback Loop: A Model of Vicious Cycle for CIPN and Acupuncture-Medication Combination

打破反馈环路：化疗诱发周围神经病变与针灸-药物联合治疗恶性循环的模型

Cancer Management and Research

IF2.6

2026-09-160

OA

Targeting cell death pathways in acute myeloid leukemia: Molecular mechanisms and clinical implications (Review)

靶向急性髓系白血病细胞死亡通路：分子机制与临床意义（综述）

ONCOLOGY REPORTS

IF3.9

2025-12-010

PRE

MiR-503-5p as a potential biomarker for deep venous thrombosis (DVT) in multiple myeloma (MM) and its role in disease development

MiR-503-5p作为多发性骨髓瘤（MM）中深静脉血栓（DVT）的潜在生物标志物及其在疾病发展中的作用

Annals of Hematology

IF2.4

2025-11-220

OAAI

Study on Risk Factors and Treatment Strategies for Deep Vein Thrombosis in Patients with Multiple Myeloma

多发性骨髓瘤患者深静脉血栓形成危险因素及治疗策略研究

pain research management

IF2.6

2025-08-150

PRE

Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B

慢性乙型肝炎患者经PEG-IFNα治疗后，HBsAg血清清除后HBeAg和HBV DNA延迟丢失的机制

EMERGING MICROBES & INFECTIONS

IF7.5

2025-04-030

OAAI

In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study

BMC INFECTIOUS DISEASES

IF3

2023-10-183

OAAI

Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure

HEPATOLOGY INTERNATIONAL

IF6.1

2023-03-224

PRE

Factors affecting prolonged SARS-CoV-2 infection and development and validation of predictive nomograms

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-02-113

PRE

A practical scoring model to predict the occurrence of critical illness in hospitalized patients with SARS-CoV-2 omicron infection

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-12-194

OAAI

Lower frequency of MDSCs was significantly related to functional cure in CHB patients treated with peginterferon

LIVER INTERNATIONAL

IF5.2

2022-12-074

PRE

Proportion of asymptomatic infection and nonsevere disease caused by SARS-CoV-2 Omicron variant: A systematic review and analysis

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2022-08-2466

OA

Identification of Estradiol Benzoate as an Inhibitor of HBx Using Inducible Stably Transfected HepG2 Cells Expressing HiBiT Tagged HBx

IF4.6

2022-08-068

OAAI

SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-2985

OAAI

High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein

NUCLEIC ACIDS RESEARCH

IF13.1

2022-02-0719

OAAI

Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2020-08-13273

OAAI